BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22105256)

  • 1. Trends in bilateral oophorectomy at the time of hysterectomy for benign disease.
    Novetsky AP; Boyd LR; Curtin JP
    Obstet Gynecol; 2011 Dec; 118(6):1280-1286. PubMed ID: 22105256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in bilateral salpingo-oophorectomy among Taiwanese women undergoing benign hysterectomy: a population-based, pooled, cross-sectional study.
    Lai JC; Huang N; Wang KL; Hu HY; Chen IT; Chou YJ
    Menopause; 2015 Jul; 22(7):765-72. PubMed ID: 25387346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
    Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
    Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate oophorectomy at time of benign premenopausal hysterectomy.
    Mahal AS; Rhoads KF; Elliott CS; Sokol ER
    Menopause; 2017 Aug; 24(8):947-953. PubMed ID: 28486247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.
    Jacoby VL; Vittinghoff E; Nakagawa S; Jackson R; Richter HE; Chan J; Kuppermann M
    Obstet Gynecol; 2009 Jun; 113(6):1259-1267. PubMed ID: 19461420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.
    Asante A; Whiteman MK; Kulkarni A; Cox S; Marchbanks PA; Jamieson DJ
    Obstet Gynecol; 2010 Nov; 116(5):1088-95. PubMed ID: 20966693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting prophylactic oophorectomy in postmenopausal women.
    Gross CP; Nicholson W; Powe NR
    Obstet Gynecol; 1999 Dec; 94(6):962-8. PubMed ID: 10576183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979-2004.
    Lowder JL; Oliphant SS; Ghetti C; Burrows LJ; Meyn LA; Balk J
    Am J Obstet Gynecol; 2010 Jun; 202(6):538.e1-9. PubMed ID: 20060093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hysterectomy with and without oophorectomy and all-cause and cause-specific mortality.
    Tuesley KM; Protani MM; Webb PM; Dixon-Suen SC; Wilson LF; Stewart LM; Jordan SJ
    Am J Obstet Gynecol; 2020 Nov; 223(5):723.e1-723.e16. PubMed ID: 32376318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987.
    Melton LJ; Bergstralh EJ; Malkasian GD; O'Fallon WM
    Epidemiology; 1991 Mar; 2(2):149-52. PubMed ID: 1932314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
    Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
    Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice variation in bilateral salpingo-oophorectomy at benign abdominal hysterectomy: a population-based study.
    Cusimano MC; Moineddin R; Chiu M; Ferguson SE; Aktar S; Liu N; Baxter NN
    Am J Obstet Gynecol; 2021 Jun; 224(6):585.e1-585.e30. PubMed ID: 33359174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral salpingo-oophorectomy at the time of benign hysterectomy among females with disabilities: a population-based cross-sectional study.
    Scime NV; Brown HK; Metcalfe A; Simpson AN; Brennand EA
    Am J Obstet Gynecol; 2023 Dec; 229(6):658.e1-658.e17. PubMed ID: 37544349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in ovarian conservation in women undergoing hysterectomy for benign indications.
    Perera HK; Ananth CV; Richards CA; Neugut AI; Lewin SN; Lu YS; Herzog TJ; Hershman DL; Wright JD
    Obstet Gynecol; 2013 Apr; 121(4):717-726. PubMed ID: 23635670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy.
    Progetto Menopausa Italia Study Group
    Maturitas; 2000 Jul; 36(1):19-25. PubMed ID: 10989238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hysterectomy status and all-cause mortality in a 21-year Australian population-based cohort study.
    Wilson LF; Pandeya N; Byles J; Mishra GD
    Am J Obstet Gynecol; 2019 Jan; 220(1):83.e1-83.e11. PubMed ID: 30312584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic oophorectomy in ovarian cancer prevention.
    Kontoravdis A; Kalogirou D; Antoniou G; Kontoravdis N; Karakitsos P; Zourlas PA
    Int J Gynaecol Obstet; 1996 Sep; 54(3):257-62. PubMed ID: 8889634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
    Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
    Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Oophorectomy at the Time of Vaginal Hysterectomy in Patients with Pelvic Organ Prolapse.
    Lua LL; Kosiorek HE; Wasson MN
    J Minim Invasive Gynecol; 2019; 26(6):1063-1069. PubMed ID: 30343033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.